Potassium Phosphates NDC 65219-056

NDC codes

FDA NDC Directory

Product NDC (as listed)65219-056Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65219-0056Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65219-056-29	65219005629	25 VIAL in 1 TRAY (65219-056-29) / 50 mL in 1 VIAL (65219-056-09)Marketed from Feb 10, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Phosphates
Generic name (nonproprietary): potassium phosphate, monobasic potassium phosphate, dibasic
Active ingredients: Monobasic potassium phosphate — 224 mg/mLDibasic potassium phosphate — 236 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 212832
Marketing start: Feb 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 65219-056_935c5395-1f0b-4277-97de-8b1cf1252d1eSPL ID 935c5395-1f0b-4277-97de-8b1cf1252d1eSPL set ID 475f5cd7-45bd-412a-b419-9962585d6cdaRxCUI 1928567, 1928569, 2667657UNII 4J9FJ0HL51, CI71S98N1ZUPC 0365219056096, 0365219052098, 0365219054092
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219005629 followed by a unit qualifier and the quantity

Package 65219-0056-29. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 28, 2025.

Indications (excerpt from the label)

Potassium Phosphates Injection is indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. • for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. Potassium Phosphates Injection is a phosphorus replacement product indicated as a source of phosphorus: • in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated. ( 1 ) • for parenteral nutrition in adults and p…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 212832

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 212832
Product	Strength	Form · route	Labeler	Product NDC
Potassium Phosphates	Monobasic potassium phosphate 11.2 mg/mL; Dibasic potassium phosphate 11.8 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-656
Potassium Phosphates	Monobasic potassium phosphate 4.48 mg/mL; Dibasic potassium phosphate 4.72 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-658
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	CIVICA, INC.	72572-232
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	65219-052
Potassium Phosphatespotassium phosphate, monobasic potassium phosphate, dibasic	Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL	Injection, Solution, ConcentrateIntravenous	Fresenius Kabi USA, LLC	65219-054